Gene-Editing Technology Heads To Court For ‘Biotech Battle Of The Century’
The technology, known as CRISPR, could be worth billions. But the legal system will now have to iron out who owns this revolutionary idea in an East Coast-West Coast patent feud.
CRISPR In Court: Legal Battle Over Patent Rights Set To Begin
The high-stakes fight over who invented a technology that could revolutionize medicine and agriculture heads to a courtroom Tuesday. A gene-editing technology called CRISPR-cas9 could be worth billions of dollars. But it's not clear who owns the idea. U.S. patent judges will hear oral arguments to help untangle this issue, which has far more at stake than your garden-variety patent dispute. (Harris, 12/5)
The Ali-Frazier Fight Of Biotech? Patent Court To Hear CRISPR Oral Arguments
It's hard not to get hype-y about CRISPR, the gene-editing tool hailed as a revolution sweeping labs around the world. The same goes for the East Coast-West Coast patent fight over credit for CRISPR that some call the biotech battle of the century. (Goldberg, 12/5)